Nova Eye Medical Ltd
ASX:EYE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nova Eye Medical Ltd
ASX:EYE
|
AU |
|
Millennium Pharmacon International Tbk PT
IDX:SDPC
|
ID |
|
V
|
Vatryggingafelag Islands hf
ICEX:VIS
|
IS |
|
C
|
Campbell Soup Co
XHAM:CSC
|
US |
|
X
|
XL Fleet Corp
F:XLF
|
US |
|
H
|
HIL Ltd
NSE:HIL
|
IN |
|
R
|
Roper Technologies Inc
NASDAQ:ROP
|
US |
Wall Street
Price Targets
EYE Price Targets Summary
Nova Eye Medical Ltd
According to Wall Street analysts, the average 1-year price target for
EYE
is 0.51 AUD
with a low forecast of 0.505 AUD and a high forecast of 0.525 AUD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is EYE's stock price target?
Price Target
0.51
AUD
According to Wall Street analysts, the average 1-year price target for
EYE
is 0.51 AUD
with a low forecast of 0.505 AUD and a high forecast of 0.525 AUD.
What is Nova Eye Medical Ltd's Revenue forecast?
Projected CAGR
21%
For the last 9 years the
compound annual growth rate for
Nova Eye Medical Ltd's revenue is
-10%.
The projected
CAGR
for the next 3 years is
21%.
